NLRP7 and the genetics of hydatidiform moles: Recent advances and new challenges

Frontiers in Immunology

Volumn 4, Issue AUG, 2013, Pages

  Slim, Rima ^a   Wallace, Evan P ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Hydatidiform mole; Maternal effect genes; NLRP7; Reproductive loss; Spontaneous abortions

Indexed keywords

CHORIONIC GONADOTROPIN; GAMMA TUBULIN; INTERLEUKIN 1BETA; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR 14; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR 2; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR 5; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR 7; UNCLASSIFIED DRUG;

ARTICLE; BECKWITH WIEDEMANN SYNDROME; CELL PROLIFERATION; CHORIOCARCINOMA; DISEASE CLASSIFICATION; ECHOGRAPHY; FERTILIZATION; FETUS HEART; GENE IDENTIFICATION; GENE MAPPING; GENE MUTATION; GENE SILENCING; GENETIC SUSCEPTIBILITY; GENOTYPE; GESTATIONAL SAC; HISTOPATHOLOGY; HUMAN; HYDATIDIFORM MOLE; KARYOTYPE; NONHUMAN; PHENOTYPE; TRANSIENT TRANSFECTION; TROPHOBLAST;

EID: 84883678511     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00242     Document Type: Article

References (116)

1. Brews A. Hydatidiform mole and chorion-epithelioma. J Obstet Gynaecol Br Emp (1939) 46(5):813-35. doi:10.1111/j.1471-0528.1939.tb07558.x
2. Ricci JV. Aetios of Amida: The Gynaecology and Obstetrics of the VI Century, A.D. Philadelphia: The Blakiston Company (1950).
3. van Trommel NE. Refinements in the Management of Persistent Trophoblastic Disease. Nijmegen: drukkerij MacDonald/ssn (2006) 179 p.
4. Savage P, Williams J, Wong SL, Short D, Casalboni S, Catalano K, et al. The demographics of molar pregnancies in England and Wales from 2000-2009. J Reprod Med (2010) 55(7-8):341-5.
5. Grimes DA. Epidemiology of gestational trophoblastic disease. Am J Obstet Gynecol (1984) 150(3):309-18.
6. Bracken MB, Brinton LA, Hayashi K. Epidemiology of hydatidiform mole and choriocarcinoma. Epidemiol Rev (1984) 6:52-75.
7. Bracken MB. Incidence and aetiology of hydatidiform mole: an epidemiological review. Br J Obstet Gynaecol (1987) 94(12):1123-35. doi:10.1111/j.1471-0528.1987.tb02311.x
8. Sebire NJ, Fisher RA, Foskett M, Rees H, Seckl MJ, Newlands ES. Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy. BJOG (2003) 110(1):22-6. doi:10.1046/j.1471-0528.2003.02388.x
9. Kim JH, Park DC, Bae SN, Namkoong SE, Kim SJ. Subsequent reproductive experience after treatment for gestational trophoblastic disease. Gynecol Oncol (1998) 71(1):108-12. doi:10.1006/gyno.1998.5167
10. Horn LC, Kowalzik J, Bilek K, Richter CE, Einenkel J. Clinicopathologic characteristics and subsequent pregnancy outcome in 139 complete hydatidiform moles. Eur J Obstet Gynecol Reprod Biol (2006) 128(1-2):10-4. doi:10.1016/j.ejogrb.2006.01.024
11. Berkowitz RS, Im SS, Bernstein MR, Goldstein DP. Gestational trophoblastic disease. Subsequent pregnancy outcome, including repeat molar pregnancy. J Reprod Med (1998) 43(1):81-6.
12. Kronfol NM, Iliya FA, Hajj SN. Recurrent hydatidiform mole: a report of five cases with review of the literature. J Med Liban (1969) 22(4):507-20.
13. Yapar EG, Ayhan A, Ergeneli MH. Pregnancy outcome after hydatidiform mole, initial and recurrent. J Reprod Med (1994) 39(4):297-9.
14. Sand PK, Lurain JR, Brewer JI. Repeat gestational trophoblastic disease. Obstet Gynecol (1984) 63(2):140-4.
15. Mack CH, Catherwood AE. The Ascheim-Zondek reaction in hydatidiform moles and malignant chorionepithelioma. Am J Obstet Gynecol (1930) 20:670-8.
16. Stone M, Bagshawe KD. Letter: hydatidiform mole: two entities. Lancet (1976) 1(7958):535. doi:10.1016/S0140-6736(76)90314-7
17. Vassilakos P, Kajii T. Letter: hydatidiform mole: two entities. Lancet (1976) 1(7953):259. doi:10.1016/S0140-6736(76)91393-3
18. Vassilakos P, Riotton G, Kajii T. Hydatidiform mole: two entities. A morphologic and cytogenetic study with some clinical consideration. Am J Obstet Gynecol (1977) 127(2):167-70.
19. Szulman AE, Surti U. The syndromes of hydatidiform mole. II. Morphologic evolution of the complete and partial mole. Am J Obstet Gynecol (1978) 132(1):20-7.
20. Howat AJ, Beck S, Fox H, Harris SC, Hill AS, Nicholson CM, et al. Can histopathologists reliably diagnose molar pregnancy? J Clin Pathol (1993) 46(7):599-602. doi:10.1136/jcp.46.7.599
21. Gupta M, Vang R, Yemelyanova AV, Kurman RJ, Li FR, Maambo EC, et al. Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis for both recently trained and experienced gynecologic pathologists. Am J Surg Pathol (2012) 36(12):1747-60. doi:10.1097/PAS.0b013e31825ea736
22. Fukunaga M, Katabuchi H, Nagasaka T, Mikami Y, Minamiguchi S, Lage JM. Interobserver and intraobserver variability in the diagnosis of hydatidiform mole. Am J Surg Pathol (2005) 29(7):942-7. doi:10.1097/01.pas.0000157996.23059.c1
23. Baasanjav B, Usui H, Kihara M, Kaku H, Nakada E, Tate S, et al. The risk of post-molar gestational trophoblastic neoplasia is higher in heterozygous than in homozygous complete hydatidiform moles. Hum Reprod (2010) 25(5):1183-91. doi:10.1093/humrep/deq052
24. Furtado LV, Paxton CN, Jama MA, Tripp SR, Wilson AR, Lyon E, et al. Diagnostic utility of microsatellite genotyping for molar pregnancy testing. Arch Pathol Lab Med (2013) 137(1):55-63. doi:10.5858/arpa.2012-0047-OA
25. Kovacs BW, Shahbahrami B, Tast DE, Curtin JP. Molecular genetic analysis of complete hydatidiform moles. Cancer Genet Cytogenet (1991) 54(2):143-52. doi:10.1016/0165-4608(91)90202-6
26. Lai CY, Chan KY, Khoo US, Ngan HY, Xue WC, Chiu PM, et al. Analysis of gestational trophoblastic disease by genotyping and chromosome in situ hybridization. Mod Pathol (2004) 17(1):40-8. doi:10.1038/modpathol.3800010
27. Lipata F, Parkash V, Talmor M, Bell S, Chen S, Maric V, et al. Precise DNA genotyping diagnosis of hydatidiform mole. Obstet Gynecol (2010) 115(4):784-94. doi:10.1097/AOG.0b013e3181d489ec
28. Sundvall L, Lund H, Niemann I, Jensen UB, Bolund L, Sunde L. Tetraploidy in hydatidiform moles. Hum Reprod (2013) 28(7):2010-20. doi:10.1093/humrep/det132
29. Jacobs PA, Szulman AE, Funkhouser J, Matsuura JS, Wilson CC. Human triploidy: relationship between parental origin of the additional haploid complement and development of partial hydatidiform mole. Ann Hum Genet (1982) 46(Pt 3):223-31. doi:10.1111/j.1469-1809.1982.tb00714.x
30. Buza N, Hui P. Partial hydatidiform mole: histologic parameters in correlation with DNA genotyping. Int J Gynecol Pathol (2013) 32(3):307-15. doi:10.1097/PGP.0b013e3182626011
31. Murphy KM, Descipio C, Wagenfuehr J, Tandy S, Mabray J, Beierl K, et al. Tetraploid partial hydatidiform mole: a case report and review of the literature. Int J Gynecol Pathol (2012) 31(1):73-9. doi:10.1097/PGP.0b013e31822555b3
32. Surti U, Szulman AE, Wagner K, Leppert M, O'Brien SJ. Tetraploid partial hydatidiform moles: two cases with a triple paternal contribution and a 92,XXXY karyotype. Hum Genet (1986) 72(1):15-21. doi:10.1007/BF00278810
33. Golubovsky MD. Postzygotic diploidization of triploids as a source of unusual cases of mosaicism, chimerism and twinning. Hum Reprod (2003) 18(2):236-42. doi:10.1093/humrep/deg060
34. Berkowitz RS, Goldstein DP. Chorionic tumors. N Engl J Med (1996) 335(23):1740-8. doi:10.1056/NEJM199612053352306
35. Seckl MJ, Sebire NJ, Berkowitz RS. Gestational trophoblastic disease. Lancet (2010) 376(9742):717-29. doi:10.1016/S0140-6736(10)60280-2
36. Garner EI, Goldstein DP, Feltmate CM, Berkowitz RS. Gestational trophoblastic disease. Clin Obstet Gynecol (2007) 50(1):112-22. doi:10.1097/GRF.0b013e31802f17fc
37. Kohorn EI. The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: description and critical assessment. Int J Gynecol Cancer (2001) 11(1):73-7. doi:10.1046/j.1525-1438.2001.011001073.x
38. Hancock BW. Staging and classification of gestational trophoblastic disease. Best Pract Res Clin Obstet Gynaecol (2003) 17(6):869-83. doi:10.1016/S1521-6934(03)00073-7
39. Goldstein DP, Berkowitz RS. Current management of gestational trophoblastic neoplasia. Hematol Oncol Clin North Am (2012) 26(1):111-31. doi:10.1016/j.hoc.2011.10.007
40. Buckely J. Choriocarcinoma. 2nd ed. In: Schottenfeld D, Fraumeni J, editors. Cancer Epidemiology and Prevention (Vol. xxi), NewYork: Oxford University Press (1996).
41. Ober WB, Edgcomb JH, Price EB Jr. The pathology of choriocarcinoma. Ann N Y Acad Sci (1971) 172(10):299-426. doi:10.1111/j.1749-6632.1971.tb34943.x
42. Cheung AN-Y. Pathology of gestational trophoblastic diseases. Best Pract Res Clin Obstet Gynaecol (2003) 17(6):849-68. doi:10.1016/S1521-6934(03)00094-4
43. Acosta-Sison H. The chance of malignancy in a repeated hydatidiform mole. Am J Obstet Gynecol (1959) 78:876-7.
44. Chesley LC, Preece J. Hydatidiform mole, with special reference to recurrence and associated eclampsia. Am J Obstet Gynecol (1946) 52:311-20.
45. Endres RJ. Hydatidiform mole. Report of a patient with 5 consecutive hydatidiform moles. Am J Obstet Gynecol (1961) 81:711-4.
46. Hsu CT, Lai CH, Changchien CL, Changchien BC. Repeat hydatidiform moles. Report of seven cases. Am J Obstet Gynecol (1963) 87:543-7.
47. Seoud M, Khalil A, Frangieh A, Zahed L, Azar G, Nuwayri-Salti N. Recurrent molar pregnancies in a family with extensive intermarriage: report of a family and review of the literature. Obstet Gynecol (1995) 86(4 Pt 2):692-5. doi:10.1016/0029-7844(95)00033-N
48. Moglabey YB, Kircheisen R, Seoud M, El Mogharbel N, Van den Veyver I, Slim R. Genetic mapping of a maternal locus responsible for familial hydatidiform moles. Hum Mol Genet (1999) 8(4):667-71. doi:10.1093/hmg/8.4.667
49. Parazzini F, La Vecchia C, Franceschi S, Mangili G. Familial trophoblastic disease: case report. Am J Obstet Gynecol (1984) 149(4):382-3.
50. La Vecchia C, Franceschi S, Fasoli M, Mangioni C. Gestational trophoblastic neoplasms in homozygous twins. Obstet Gynecol (1982) 60(2):250-2.
51. Kircheisen R, Schroeder-Kurth T. Familial hydatidiform mole syndrome and genetic aspects of this disturbed trophoblast development. Geburtshilfe Frauenheilkd (1991) 51(7):569-71. doi:10.1055/s-2007-1026201
52. Ambani LM, Vaidya RA, Rao CS, Daftary SD, Motashaw ND. Familial occurrence of trophoblastic disease - report of recurrent molar pregnancies in sisters in three families. Clin Genet (1980) 18(1):27-9. doi:10.1111/j.1399-0004.1980.tb01360.x
53. Zhao J, Moss J, Sebire NJ, Cui QC, Seckl MJ, Xiang Y, et al. Analysis of the chromosomal region 19q13.4 in two Chinese families with recurrent hydatidiform mole. Hum Reprod (2006) 21(2):536-41. doi:10.1093/humrep/dei357
54. Slim R, Bagga R, Chebaro W, Srinivasan R, Agarwal N. A strong founder effect for two NLRP7 mutations in the Indian population: an intriguing observation. Clin Genet (2009) 76(3):292-5. doi:10.1111/j.1399-0004.2009.01189.x
55. Sensi A, Gualandi F, Pittalis MC, Calabrese O, Falciano F, Maestri I, et al. Mole maker phenotype: possible narrowing of the candidate region. Eur J Hum Genet (2000) 8(8):641-4. doi:10.1038/sj.ejhg.5200501
56. Reddy R, Akoury E, Phuong Nguyen NM, Abdul-Rahman OA, Dery C, Gupta N, et al. Report of four new patients with protein-truncating mutations in C6orf221/KHDC3L and colocalization with NLRP7. Eur J Hum Genet (2012). doi:10.1038/ejhg.2012.274 [Epub ahead of print].
57. Qian J, Deveault C, Bagga R, Xie X, Slim R. Women heterozygous for NALP7/NLRP7 mutations are at risk for reproductive wastage: report of two novel mutations. Hum Mutat (2007) 28(7):741. doi:10.1002/humu.9498
58. Mazhar S, Janjua S. Recurrent familial hydatidiform mole. J Pakistan Inst Med Sci (1995) 6(1, 2):383-6.
59. Landolsi H, Rittore C, Philibert L, Missaoui N, Hmissa S, Touitou I, et al. Screening for NLRP7 mutations in familial and sporadic recurrent hydatidiform moles: report of 2 Tunisian families. Int J Gynecol Pathol (2011) 30(4):348-53. doi:10.1097/PGP.0b013e31820dc3b0
60. Kou YC, Shao L, Peng HH, Rosetta R, del Gaudio D, Wagner AF, et al. A recurrent intragenic genomic duplication, other novel mutations in NLRP7 and imprinting defects in recurrent biparental hydatidiform moles. Mol Hum Reprod (2008) 14(1):33-40. doi:10.1093/molehr/gam079
61. Judson H, Hayward BE, Sheridan E, Bonthron DT. A global disorder of imprinting in the human female germ line. Nature (2002) 416(6880):539-42. doi:10.1038/416539a
62. Hodges MD, Rees HC, Seckl MJ, Newlands ES, Fisher RA. Genetic refinement and physical mapping of a biparental complete hydatidiform mole locus on chromosome 19q13.4. J Med Genet (2003) 40(8):e95. doi:10.1136/jmg.40.8.e95
63. Hayward BE, De Vos M, Talati N, Abdollahi MR, Taylor GR, Meyer E, et al. Genetic and epigenetic analysis of recurrent hydatidiform mole. Hum Mutat (2009) 30(5):E629-39. doi:10.1002/humu.20993
64. Fisher RA, Hodges MD, Rees HC, Sebire NJ, Seckl MJ, Newlands ES, et al. The maternally transcribed gene p57(KIP2) (CDNK1C) is abnormally expressed in both androgenetic and biparental complete hydatidiform moles. Hum Mol Genet (2002) 11(26):3267-72. doi:10.1093/hmg/11.26.3267
65. Fallahian M. Familial gestational trophoblastic disease. Placenta (2003) 24(7):797-9. doi:10.1016/S0143-4004(03)00105-X
66. Estrada H, Buentello B, Zenteno JC, Fiszman R, Aguinaga M. The p.L750V mutation in the NLRP7 gene is frequent in Mexican patients with recurrent molar pregnancies and is not associated with recurrent pregnancy loss. Prenat Diagn (2013) 33(3):205-8. doi:10.1002/pd.4036
67. Deveault C, Qian JH, Chebaro W, Ao A, Gilbert L, Mehio A, et al. NLRP7 mutations in women with diploid androgenetic and triploid moles: a proposed mechanism for mole formation. Hum Mol Genet (2009) 18(5):888-97. doi:10.1093/hmg/ddn418
68. Agarwal P, Bagga R, Jain V, Kalra J, Gopalan S. Familial recurrent molar pregnancy: a case report. Acta Obstet Gynecol Scand (2004) 83(2):213-4. doi:10.1080/j.0001-6349.2004.077b.x
69. Abdalla EM, Hayward BE, Shamseddin A, Nawar MM. Recurrent hydatidiform mole: detection of two novel mutations in the NLRP7 gene in two Egyptian families. Eur J Obstet Gynecol Reprod Biol (2012) 164(2):211-5. doi:10.1016/j.ejogrb.2012.06.017
70. Murdoch S, Djuric U, Mazhar B, Seoud M, Khan R, Kuick R, et al. Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans. Nat Genet (2006) 38(3):300-2. doi:10.1038/ng1740
71. Puechberty J, Rittore C, Philibert L, Lefort G, Burlet G, Benos P, et al. Homozygous NLRP7 mutations in a Moroccan woman with recurrent reproductive failure. Clin Genet (2009) 75(3):298-300. doi:10.1111/j.1399-0004.2008.01098.x
72. Wang M, Dixon PH, Decordova S, Hodges M, Sebire NJ, Ozalp S, et al. Identification of 13 novel NLRP7 mutations in 20 families with recurrent hydatidiform mole; missense mutations cluster in the leucine rich region. J Med Genet (2009) 46(8):569-75. doi:10.1136/jmg.2008.064196
73. Milhavet F, Cuisset L, Hoffman HM, Slim R, El-Shanti H, Aksentijevich I, et al. The infevers autoinflammatory mutation online registry: update with new genes and functions. Hum Mutat (2008) 29(6):803-8. doi:10.1002/humu.20720
74. Peltonen L, Perola M, Naukkarinen J, Palotie A. Lessons from studying monogenic disease for common disease. Hum Mol Genet (2006) 15:R67-74. doi:10.1093/hmg/ddl060
75. Okada K, Hirota E, Mizutani Y, Fujioka T, Shuin T, Miki T, et al. Oncogenic role of NALP7 in testicular seminomas. Cancer Sci (2004) 95(12):949-54. doi:10.1111/j.1349-7006.2004.tb03182.x
76. Kinoshita T, Wang Y, Hasegawa M, Imamura R, Suda T. PYPAF3, a PYRIN-containing APAF-1-like protein, is a feedback regulator of caspase-1-dependent interleukin-1{beta} secretion. J Biol Chem (2005) 280(23):21720-5. doi:10.1074/jbc.M410057200
77. Zhang P, Dixon M, Zucchelli M, Hambiliki F, Levkov L, Hovatta O, et al. Expression analysis of the NLRP gene family suggests a role in human preimplantation development. PLoS ONE (2008) 3(7):e2755. doi:10.1371/journal.pone.0002755
78. Messaed C, Akoury E, Djuric U, Zeng J, Saleh M, Gilbert L, et al. NLRP7, a nucleotide oligomerization domain-like receptor protein, is required for normal cytokine secretion and co-localizes with Golgi and the microtubule-organizing center. J Biol Chem (2011) 286(50):43313-23. doi:10.1074/jbc.M111.306191
79. Aravind L, Dixit VM, Koonin EV. The domains of death: evolution of the apoptosis machinery. Trends Biochem Sci (1999) 24(2):47-53. doi:10.1016/S0968-0004(98)01341-3
80. Koonin EV, MY G. Sequence - Evolution - Function: Computational Approaches in Comparative Genomics. Boston: Kluwer Academic (2003).
81. Kobe B, Deisenhofer J. Mechanism of ribonuclease inhibition by ribonuclease inhibitor protein based on the crystal structure of its complex with ribonuclease A. J Mol Biol (1996) 264(5):1028-43. doi:10.1006/jmbi.1996.0694
82. Khare S, Dorfleutner A, Bryan NB, Yun C, Radian AD, de Almeida L, et al. An NLRP7-containing inflammasome mediates recognition of microbial lipopeptides in human macrophages. Immunity (2012) 36(3):464-76. doi:10.1016/j.immuni.2012.02.001
83. Coulam CB, Wagenknecht D, McIntyre JA, Faulk WP, Annegers JF. Occurrence of other reproductive failures among women with recurrent spontaneous abortion. Am J Reprod Immunol (1991) 25(3):96-8. doi:10.1111/j.1600-0897.1991.tb01073.x
84. Messaed C, Chebaro W, Roberto RB, Rittore C, Cheung A, Arseneau J, et al. NLRP7 in the spectrum of reproductive wastage: rare non-synonymous variants confer genetic susceptibility to recurrent reproductive wastage. J Med Genet (2011) 48(8):540-8. doi:10.1136/jmg.2011.089144
85. Dixon PH, Trongwongsa P, Abu-Hayyah S, Ng SH, Akbar SA, Khawaja NP, et al. Mutations in NLRP7 are associated with diploid biparental hydatidiform moles, but not androgenetic complete moles. J Med Genet (2012) 49(3):206-11. doi:10.1136/jmedgenet-2011-100602
86. Landolsi H, Rittore C, Philibert L, Hmissa S, Gribaa M, Touitou I, et al. NLRP7 mutation analysis in sporadic hydatidiform moles in Tunisian patients: NLRP7 and sporadic mole. Arch Pathol Lab Med (2012) 136(6):646-51. doi:10.5858/arpa.2011-0399-OA
87. Qian J, Cheng Q, Murdoch S, Xu C, Jin F, Chebaro W, et al. The genetics of recurrent hydatidiform moles in China: correlations between NLRP7 mutations, molar genotypes, and reproductive outcomes. Mol Hum Reprod (2011) 17(10):612-9. doi:10.1093/molehr/gar027
88. Slim R, Coullin P, Diatta AL, Chebaro W, Courtin D, Abdelhak S, et al. NLRP7 and the genetics of post-molar choriocarcinomas in Senegal. Mol Hum Reprod (2012) 18(1):52-6. doi:10.1093/molehr/gar060
89. Manokhina I, Hanna CW, Stephenson MD, McFadden DE, Robinson WP. Maternal NLRP7 and C6orf221 variants are not a common risk factor for androgenetic moles, triploidy and recurrent miscarriage. Mol Hum Reprod (2013) 19(8):539-44. doi:10.1093/molehr/gat019
90. Abou-Sleiman PM, Muqit MM, McDonald NQ, Yang YX, Gandhi S, Healy DG, et al. A heterozygous effect for PINK1 mutations in Parkinson's disease? Ann Neurol (2006) 60(4):414-9. doi:10.1002/ana.20960
91. Bonifati V, Rohe CF, Breedveld GJ, Fabrizio E, De Mari M, Tassorelli C, et al. Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes. Neurology (2005) 65(1):87-95. doi:10.1212/01.wnl.0000167546.39375.82
92. Lesage S, Lohmann E, Tison F, Durif F, Durr A, Brice A. Rare heterozygous parkin variants in French early-onset Parkinson disease patients and controls. J Med Genet (2008) 45(1):43-6. doi:10.1136/jmg.2007.051854
93. Podhajska A, Musso A, Trancikova A, Stafa K, Moser R, Sonnay S, et al. Common pathogenic effects of missense mutations in the P-type ATPase ATP13A2 (PARK9) associated with early-onset parkinsonism. PLoS ONE (2012) 7(6):e39942. doi:10.1371/journal.pone.0039942
94. Lesage S, Anheim M, Condroyer C, Pollak P, Durif F, Dupuits C, et al. Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson's disease. Hum Mol Genet (2011) 20(1):202-10. doi:10.1093/hmg/ddq454
95. Sidransky E, Nalls MA, Aasly JO, Aharon-Peretz J, Annesi G, Barbosa ER, et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med (2009) 361(17):1651-61. doi:10.1056/NEJMoa0901281
96. Cohen JC, Kiss RS, Pertsemlidis A, Marcel YL, McPherson R, Hobbs HH. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science (2004) 305(5685):869-72. doi:10.1126/science.1099870
97. Kone-Paut I, Hentgen V, Guillaume-Czitrom S, Compeyrot-Lacassagne S, Tran TA, Touitou I. The clinical spectrum of 94 patients carrying a single mutated MEFV allele. Rheumatology (Oxford) (2009) 48(7):840-2. doi:10.1093/rheumatology/kep121
98. Helwani MN, Seoud M, Zahed L, Zaatari G, Khalil A, Slim RA. familial case of recurrent hydatidiform molar pregnancies with biparental genomic contribution. Hum Genet (1999) 105(1-2):112-5. doi:10.1007/s004390051071
99. Panichkul PC, Al-Hussaini TK, Sierra R, Kashork CD, Popek EJ, Stockton DW, et al. Recurrent biparental hydatidiform mole: additional evidence for a 1.1-Mb locus in 19q13.4 and candidate gene analysis. J Soc Gynecol Investig (2005) 12(5):376-83. doi:10.1016/j.jsgi.2005.02.011
100. Sebire NJ, Savage PM, Seckl MJ, Fisher RA. Histopathological features of biparental complete hydatidiform moles in women with NLRP7 mutations. Placenta (2013) 34(1):50-6. doi:10.1016/j.placenta.2012.11.005
101. Fallahian M, Sebire NJ, Savage PM, Seckl MJ, Fisher RA. Mutations in NLRP7 and KHDC3L confer a complete hydatidiform mole phenotype on digynic triploid conceptions. Hum Mutat (2013) 34(2):301-8. doi:10.1002/humu.22228
102. Slim R, Ao A, Surti U, Zhang L, Hoffner L, Arseneau J, et al. Recurrent triploid and dispermic conceptions in patients with NLRP7 mutations. Placenta (2011) 32(5):409-12. doi:10.1016/j.placenta.2011.02.001
103. Tong ZB, Gold L, Pfeifer KE, Dorward H, Lee E, Bondy CA, et al. Mater, a maternal effect gene required for early embryonic development in mice. Nat Genet (2000) 26(3):267-8. doi:10.1038/81547
104. Kojima A, Prehn RT. Genetic susceptibility to post-thymectomy autoimmune diseases in mice. Immunogenetics (1981) 14(1-2):15-27. doi:10.1007/BF00344296
105. Wu X. Maternal depletion of NLRP5 blocks early embryogenesis in rhesus macaque monkeys (Macaca mulatta). Hum Reprod (2009) 24(2):415-24. doi:10.1093/humrep/den403
106. Tashiro F, Kanai-Azuma M, Miyazaki S, Kato M, Tanaka T, Toyoda S, et al. Maternal-effect gene Ces5/Ooep/Moep19/Floped is essential for oocyte cytoplasmic lattice formation and embryonic development at the maternal-zygotic stage transition. Genes Cells (2011) 15(8):813-28. doi:10.1111/j.1365-2443.2010.01420.x
107. Kim B, Kan R, Anguish L, Nelson LM, Coonrod SA. Potential role for MATER in cytoplasmic lattice formation in murine oocytes. PLoS ONE (2010) 5(9):e12587. doi:10.1371/journal.pone.0012587
108. Fernandes R, Tsuda C, Perumalsamy AL, Naranian T, Chong J, Acton BM, et al. NLRP5 mediates mitochondrial function in mouse oocytes and embryos. Biol Reprod (2012) 86(5):138. doi:10.1095/biolreprod.111.093583
109. Hamatani T, Falco G, Carter MG, Akutsu H, Stagg CA, Sharov AA, et al. Age-associated alteration of gene expression patterns in mouse oocytes. Hum Mol Genet (2004) 13(19):2263-78. doi:10.1093/hmg/ddh241
110. Westerveld GH, Korver CM, van Pelt AMM, Leschot NJ, van der Veen F, Repping S, et al. Mutations in the testis-specific NALP14 gene in men suffering from spermatogenic failure. Hum Reprod (2006) 21(12):3178-84. doi:10.1093/humrep/del293
111. Hughes AL. Evolutionary relationships of vertebrate NACHT domain-containing proteins. Immunogenetics (2006) 58(10):785-91. doi:10.1007/s00251-006-0148-8
112. McDaniel P, Wu X. Identification of oocyte-selective NLRP genes in rhesus macaque monkeys (Macaca mulatta). Mol Reprod Dev (2009) 76(2):151-9. doi:10.1002/mrd.20937
113. Tian X, Pascal G, Monget P. Evolution and functional divergence of NLRP genes in mammalian reproductive systems. BMC Evol Biol (2009) 9:202. doi:10.1186/1471-2148-9-202
114. Meyer E, Lim D, Pasha S, Tee LJ, Rahman F, Yates JR, et al. Germline mutation in NLRP2 (NALP2) in a familial imprinting disorder (Beckwith-Wiedemann Syndrome). PLoS Genet (2009) 5(3):e1000423. doi:10.1371/journal.pgen.1000423
115. Peng H, Chang B, Lu C, Su J, Wu Y, Lv P, et al. Nlrp2, a maternal effect gene required for early embryonic development in the mouse. PLoS ONE (2012) 7(1):e30344. doi:10.1371/journal.pone.0030344
116. Chang BH, Liu X, Liu J, Quan FS, Guo ZK, Zhang Y. Developmental expression and possible functional roles of mouse Nlrp4e in preimplantation embryos. In vitro Cell Dev Biol Anim (2013) 49(7):548-53. doi:10.1007/s11626-013-9638-9